期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 23, 期 23, 页码 -出版社
MDPI
DOI: 10.3390/ijms232315295
关键词
tuberculosis; antimycobacterial; oxadiazole; hydrazide; InhA; MIC
资金
- CINECA Award
- FRA2020 Research Fund (University of Trieste) [HP10CKYM0P]
We designed and synthesized a library of hydrazide derivatives to screen for novel antimycobacterial molecules. In vitro tests showed that five compounds had high activity against M. tuberculosis H37Ra attenuated strain and two compounds were effective against pyrazinamide-resistant strains. The compounds showed no antimycotic activity and low cytotoxicity against human cells. Molecular modeling suggested a plausible mechanism of action towards the active site of the InhA enzyme. The compounds were predicted to be potentially orally absorbed in humans.
To extend our screening for novel antimycobacterial molecules, we have designed, synthesized, and biologically evaluated a library of 14 new hydrazide derivatives containing 1,3,4-oxadiazole core. A variety of mycobacterial strains, including some drug-resistant strains, were tested for antimycobacterial activity. Among the compounds tested, five showed high antimycobacterial activity (MIC values of 8 mu g/mL) against M. tuberculosis H37Ra attenuated strain, and two derivatives were effective (MIC of 4 mu g/mL) against pyrazinamide-resistant strains. Furthermore, the novel compounds were tested against the fungal C. albicans strain, showing no antimycotic activity, and thus demonstrating a good selectivity profile. Notably, they also exhibited low cytotoxicity against human SH-SY5Y cells. The molecular modeling carried out suggested a plausible mechanism of action towards the active site of the InhA enzyme, which confirmed our hypothesis. In conclusion, the active compounds were predicted in silico for ADME properties, and all proved to be potentially orally absorbed in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据